Haemolytic anaemias
Haemolytic anaemias (HAs)
‱ HAs are defined as those anaemias
which result from an increase in the
rate of red cell destruction.
‱ Because of erythropoietic hyperplasia
and anatomical extension of bone
marrow, red cell destruction may be
increased several fold before the
patient become anaemic ---
compensated haemolytic anaemia.
‱ The normal adult marrow, after full
expansion, is able to produce red cells
at 6-8 times the normal rate.
Classification of HA
‱ The HA can be classified in several different
ways:
1- Site of haemolysis:
‱ Extravascular haemolytic disorders -
macrophages of the RES
‱ Intravascular haemolytic disorders- within the
circulatory system
‱ In many of the cases there is a combination of
both extra and intravascular haemolysis.
Extravascular haemolysis
‱ Red cell destruction
usually occurs in the
cell of the RES.
Intravascular haemolysis
‱ Destruction of red
cells occur inside the
blood vessels.
Cont
.
2- Site of defect:
‱ Intrinsic defect (intracorpuscular)-
structural or functional defect within the
red cell.
‱ Extrinsic defect (extracorpuscular)- an
abnormality in the red cell environment.
Cont

3- Inherited or acquired:
‱ Inherited HA are usually caused by intrinsic
defect.
‱ While acquired HA are caused by an extrinsic
defect.
‱ However there are some exceptions:
Paroxysmal nocturnal haemoglobinuria (PNH)
which is an acquired intrinsic defect, and
severe hereditary G6PD enz deficiency which
requires the presence of an extrinsic trigger
such as the antimalarial drug for the intrinsic
defect to manifest.
Inherited & acquired HA
Hereditary HA
‱ Membrane defects e.g
hereditary spherocytosis
‱ Metabolic defect e.g
G6PD deficiency.
‱ Haemoglobin defects
e.g sickle cell disease.
Acquired HA
– Immune
-Autoimmune eg AIHA
-Alloimmune e.g HDN,
HTR
– Red cell
fragmentation
syndromes
– March
haemoglobinuria
– Infections
– Chemical and physical
agents.
– PNH
Approach to the diagnosis of
haemolytic anaemias.
Patient’s history
‱ Good history is essential to provide guidance for
the diagnosis of haemolytic disorders. The
following points should not be neglected:
‱ Family history--- hereditary conditions, mode of
inheritance.
‱ Ethnic origin--- G6PD deficiency is most
common in Mediterranean and Chinese
populations.
‱ Past history--- Neonatal jaundice may be
indicative of congenital conditions as HS or
G6PD deficiency.
‱ Triggering events--- history of drugs, infections
Clinical features
‱ Pallor of the mucous membranes
‱ Mild fluctuating jaundice
‱ Splenomegaly
‱ Dark urine
‱ Pigment gall stones.
‱ Ulcers around the ankle
‱ Aplastic crisis may complicate viral infections.
‱ Growth retardation
‱ Hypertrophic skeletal changes
‱ Leg ulcers in
patients with severe
congenital
haemolytic
disorders. e.g sickle
cell anaemia
‱ Skeletal changes in
patients with b
thalassaemia.
Laboratory findings
‱ The lab. Findings are divided into 3
groups:
1- Features of increased red cell
breakdown.
2- Features of increased red cell
production.
3- Damaged red cells.
Laboratory findings
1-Features of increased red cell
breakdown:
‱ Raised S.bilirubin, unconjugated and
bound to albumin.
‱ Increased urine urobilinogen.
‱ Increased faecal stercobilinogen.
‱ Absent S.haptoglobins (saturated with
Hb and removed by the RE cells).
Laboratory findings
2-Features of increased red cell
production:
‱ Reticulocytosis
‱ Bone marrow erythroid hyperplasia.
Laboratory findings
‱ 3-Damaged red cells:
‱ Morphology– microspherocytes,
elliptocytes, fragments, etc.,
.
‱ Special tests: Osmotic fragility,
autohaemolysis
..
‱ Red cell survival is shortened; this is
best shown by 51Cr labelling with study
of the sites of destruction.
‱ Reticulocytosis is a
feature of increased
red cell production.
‱ New methylene blue
is used to stain the
reticulocytes
‱ Fragmented cells,
and bitten cells are
sings of damaged
cells occurring in
haemolysis
Intravascular haemolysis
Intravascular haemolysis
‱ Free Hb will be released from damaged red
cells.
‱ This free Hb will rapidly saturates plasma
haptoglobins. The complex will be removed
by the liver.
‱ The excess free Hb is filtered by the
glomerulus, and free Hb will enter the urine,
as iron is released, the renal tubules become
loaded with haemosiderin.
‱ Methaemalbumin and haemopexin are also
found in the process of IV haemolysis.
‱ The process of
intravascular
haemolysis
‱ Liberation of free Hb
‱ Filtered through the
kidney
‱ Appear in urine as
haemoglobinuria
Lab features of intravascular
haemolysis
‱ Haemoglobinaemia & haemoglobinuria.
‱ Haemosiderinuria (iron storage protein
in the spun deposit of urine).
‱ Methaemalbumin (detected by
Schumm‟s test).
Haemoglobinuria
‱ Notice the dark
colour of urine
compared to the
normal colour in the
other container.
‱ This is a sign of
intravascular
haemolysis.
Conclusion
‱ Good history taking is essential in guiding the
physician towards the correct diagnosis.
‱ Clinical findings seldom are sufficient to
enable a definitive diagnosis of a particular
haemolytic condition to be made.
‱ Lab investigations play a central role in the
accurate diagnosis of haemolysis.
Inherited haemolytic anaemias
Hereditary haemolytic anaemias
‱ Membrane defects – congenital
spherocytosis
‱ Metabolic defects – G6PD enzyme
deficiency
‱ Haemoglobin defects
– Qualitative defects – sickle cell anaemia
– Quantitative defects – Thalassaemia
Membrane defects
The clinical phenotypes of hereditary
membrane disorders
The mutations affecting the red cell
membrane are many, but the effect on the
phenotype can be classified into 5 main
categories.
‱ Hereditary spherocytosis
‱ Hereditary elliptocytosis and Hereditary
pyropoikilocytosis
‱ South-East Asian ovalocytosis
‱ Hereditary acanthocytosis
‱ Hereditary stomatocytosis
Hereditary spherocytosis (HS)
‱ It is the most common hereditary
haemolytic anaemia in North
Europeans.
‱ The prevalence is 200-300 per million in
the population (European population).
Pathogenesis of HS
‱ It is caused by a defect in the proteins
involved in the interactions between the
membrane cytoskeleton and the lipid bilayer
of the red cell.
‱ About 60% of HS cases result from a defect
in the ankyrin-spctrin complex.
‱ A further 25% involve deficiency in band 3,
the anion channel.
‱ In the remainder, there is a deficiency of
protein 4.2 or no abnormality detected.
Clinical features
‱ The inheritance is autosomal dominant.
‱ Rarely it may be autosomal recessive.
‱ The anaemia may present at any age from
infancy to old age.
‱ Jaundice is fluctuating.
‱ HS is also called “familial acholuric jaundice”
emphasizing the presence of jaundice in
absence of bile in urine.
‱ Splenomegaly occurs in most of the patients.
‱ Pigment gall stones are frequent.
Haematological findings in HS
‱ Features of extravascular haemolysis
are present.
‱ Anaemia is usual.
‱ Reticulocytosis 5-20%
‱ Microspherocytes are seen in the blood
film. (densely staining with smaller
diameters than normal red cells).
Microspheroctes and NRBC
Other investigations
‱ The classic finding is that the osmotic
fragility is increased in HS with a shift of
the curve to the right.
‱ Autohaemolysis is increased and
corrected by glucose.
‱ Direct antiglobulin test (Coombs test) is
normal.
Autohaemolysis test in HS
There is increased
haemolysis in the
patient in
comparison with the
control. Glucose has
given partial
correction.
Treatment
‱ Patients with well-compensated haemolysis
and no transfusion requirements need no
treatment other than reassurance and folic
acid supplements.
‱ The principal form of treatment is
splenectomy although this should not be
performed unless clinically indicated because
of the risk of post-splenectomy sepsis,
particularly in early childhood.
Hereditary elliptocytosis (HE)
‱ HE is inherited as an autosomal-dominant
trait except for a rare Melanesian type that
inherited as a recessive trait. The disorder
occurs in all racial groups with an occurrence
of .02% to 0.05%.
‱ The disease is heterogeneous in the degree
of haemolysis and clinical severity. The
prominent peripheral blood finding is an
increase in oval and elongated cells
(elliptocytes).
Pathophysiology
‱ The principal defect involves horizontal
membrane interactions.
1) Decreased association of Spectrin dimmers
to form tetramers due to defective spectrin
chains.
2) Deficiency or defective in band 4.1 which
aids in binding spectrin to actin.
3) Defective association of spectrin –
ankyrin due to spectrin chains
mutants.
Pathophysiology
‱ Each of these defects can lead to skeletal
disruptions that can cause the cell to become
elliptical in shape and/or fragment under the
stresses of circulation depending on the extent of
the defect.
‱ Mildly dysfunction proteins cause only
elliptocytosis ; whereas, severely dysfunctional
proteins cause membrane fragmentation in
addition to elliptocytosis.
Pathophysiology
‱ Elliptocytosis with membrane fragmentation causes
decrease in cell surface area and reduced cells
deformability.
‱ The lifespan of these cells is severely shortened.
‱ HE erythrocytes are abnormally permeable to Na+.
‱ This altered permeability demands an increase in
ATP to maintain osmotic equilibrium.
‱ In the spleen the cell quickly deplete their ATP and
become osmotically fragile.
Clinical finding
‱ Ninety percent of patients with HE show no
signs of haemolysis.
‱ Patients have compensated haemolytic
disease.
‱ Anaemia is not characteristic.
Lab- finding
‱ The most consistent and characteristic lab finding in all
variants is prominent elliptocytosis. Haemoglobin levels are
usually greater than 12 g/l.
‱ Reticulocytes are mildly elevated to 4%.
‱ In HE variant haemoglobin is 9 to 10 g/dl, and reticulocyte
are elevated to 20%.
‱ Microelliptocyte, schistocytes, and spherocytes are usually
evidence.
‱ Bone marrow show erythroid hyperplasia with normal
maturation.
Hereditary stomatocytosis
‱ It is a rare autosomal-dominant haemolytic
anaemia in which the erythrocyte membrane is
abnormally permeable to both Na+ and K+.
‱ As a result, the intracellular concentration of
cations increases, water inters the cell, and the
overhydrated cells take on the appearance of
stomatocytes.
‱ Stomatocytes on dried stained blood films are
erythrocytes with a slit-like (mouth-like) area of
pallor.
Pathophysiology
‱ The stomatocytes cells are osmotically
fragile and less deformable than normal
cells and as a result the cells are
sequestered in the spleen and
phagocytosed.
Lab. Finding
‱ Anemia is usually mild (8 to 10 g/dl).
‱ Bilirubin is increased.
‱ Reticulocytosis is moderate.
‱ The blood film is remarkable for 10 to
50% stomatocytes.
‱ Osmotic fragility and autohaemolysis
are increased.
‱ Autohaemolysis is partially corrected
with glucose and ATP.
Lab. finding
‱ Inherited stomatocytosis must be
differentiated from acquired causes of
stomatocytosis.
‱ Stomatocytosis also are seen in an
acquired defect in acute alcoholism, liver
disease, and cardiovascular disease.
‱ In these acquired conditions there is no
cation leaks, and little haemolysis is
present.
South-East Asian ovalocytosis
‱ This is common in Malaysia, Indonesia
and the Philippines.
‱ It is due to Band 3 protein abnormality.
‱ The cells are rigid and resist invasion by
malaria parasite.
‱ Most cases are asymptomatic.
Blood film in hereditary stomato-
ovalocytosis
‱ basophilic stippling
and numerous
stomatocytes.
Defective red cell metabolism
G6PD enzyme deficiency
Pyruvate kinase deficiency
‱ G6PD functions to
reduce nicotinamide
adenine dinucleotide
phosphate (NADPH)
while oxidizing
glucose-6-
phosphate.
‱ NADPH is needed for
the production of
reduced glutathione
(GSH) which is
important to defend
the red cells against
oxidant stress.
G6PD deficiency
‱ More than 400 variants due to point
mutations or deletions of the enzyme G6PD
have been characterized which show less
activity than normal.
‱ Worldwide over 400 million people are G6PD
deficient in enzyme activity.
Clinical features
There are four main syndromes associated
with G6PD enzyme deficiency.
‱ Neonatal jaundice (class I,II,III)
‱ Favism (class II)
‱ Chronic non spherocytic haemolytic anaemia
(CNSHA) (class I)
‱ Drug induced haemolytic anaemia (class III)
G6PD deficiency
‱ The inheritance is sex-linked, affecting
males, and carried by females.
‱ The main races affected are in West
Africa, the Mediteranean, the Middle
East, and South East Asia.
Lab Diagnosis
‱ Between crises blood count is normal.
‱ The enzyme deficiency is detected by
– One of a number of screening tests or
– By direct enzyme assay on red cells.
‱ During the crisis, the blood film may show
contracted and fragmented cells, bite and
blister cells.
‱ Enzyme assay may give a false normal level
in the phase of acute haemolysis.
‱ There are features of intravascular
haemolysis.
G6PD deficiency
‱ The blood film shows
irregularly contracted
cells [deep red arrows]
and sometimes
hemighosts [deep blue
arrow] in which all the
haemoglobin appears to
have retracted to one
side of the erythrocyte.
Management
‱ Education in the avoidance of oxidising
substances is important
‱ The offending drug is stopped.
‱ Any underlying infection is treated.
‱ High fluid intake is encouraged to avoid
renal failure.
‱ Blood transfusion, if necessary, for
severe anaemia.
Pyruvate kinase deficiency
Deficiency of glycolytic enzymes
‱ Most common after G6PD def
– Deficient ATP production, chronic haemolytic anemia
‱ Autosomal recessive - Rare [prevalence 1/10,000]
Clinical features
‱ Most are jaundice and anemic infancy and childhood
‱ Occasional mild diagnosed only in adulthood
‱ Hydrops fetalis
‱ Compensated haemolytic anemia
‱ Neonatal jaundice
‱ Gallstone
‱ Frontal bossing
Lab finding
‱ Severity of anaemia varies widley (4 – 10
g/dl).
‱ P. Smear: poikilocytosis prikle cells contracted
RBCs with spicules.
‱ Direct enzyme assay (decreased enzyme
activity)
‱ Rise of intracellular 2,3-DPG (reduce severity)
‱ Autohaolysis increased not corrected by
glucose as in HS.
Defective haemoglobin
(Haemoglobinopathies)
Haemoglobinopathies:
‱Sickle cell anaemia.
‱Thalassaemias.
‱Haemoglobin C disease.
‱Haemoglobin S/C disease.
‱Haemoglobin D (Punjab, Los Angelos).
‱Haemoglobin E.
‱Unstable haemoglobin.
Sickle cell anaemia
Defective haemoglobin
Sickle cell anaemia
‱ It is group of haematological disorders results
from single base change in the DNA coding for
the amino acid in the sixth position in the b-
globin chain. This leads to an amino acid
change from glutamic acid to valine  HbS
will be formed instead of the normal Hb.
Sickle cell anaemia
‱ Hb S is insoluble and forms crystals when
exposed to low oxygen tension.
‱ Deoxygenated sickle Hb polymerizes into long
fibrils.
‱ The red cells sickle and may block the
different areas of the microcirculation or large
vessels causing infarcts of various organs.
‱ It is widespread in West Africa.
Classification
‱ Sickle cell trait (heterozygote).
‱ Sickle cell disease (homozygote).
Pathophysiology of sickle cell disease
Clinical finding in sickle cell disease
‱ Vaso-occlusitve crisis lead to infarction in several
organs such as bones, lung, spleen and brain.
‱ Visceral sequestration crises eg. Sickle chest
syndrome.
‱ Aplastic crises due to infection or folate def. sudden
fall in Hb.
‱ Haemolytic crises increase rate of haemolysis with
fall in Hb and accompany by painful crises.
‱ Leg ulcer.
‱ Leg hand syndrome.
‱ Spleen enlargement.
Laboratory findings
‱ Hb is usually 6-9 g/dl.
‱ Sickle cells and target cells occur in the blood.
‱ Screening tests for sickling are positive.
‱ Hb electrophoresis in Hb SS, no Hb A is
detected. The amount of Hb F is variable 5-
15%.
Sickle
Cells
Erythroblasts
Howell-
Jolly Body
Sickle Cell Anemia – blood film
Sickle cell trait
‱ Sickle cell trait is heterozygous ÎČs state
(HbAS).
‱ The patient has one normal ÎČ-gene and one
abnormal ÎČs –gene .
‱ Hb A constitute more than 50% of total Hb
in these individuals so there is no clinical
symptoms .
‱ Complication of splenic infarction is possible if
the affected individuals exposed to prolong
hypoxia.
Other Sickling Disorders
Other types of Hb combine with sickle Hb
2. Hemoglobin S-C disease
– Sickle haemoglobin (HbS) + (HbC)
3. Hemoglobin S-Beta thalassemia
– Beta thalassaemia gene reduces the
amount of HbA that can be made
– Sickle haemoglobin (HbS) + reduced HbA
– Milder form of Sickle Cell Disorder than
sickle cell anemia
Thalassaemias
Definition
‱ Thalassaemias are heterogeneous group
of genetic disorders due to mutation that
causes decrease in the rate of synthesis
of one of the constituent globins chains
,usually α or ÎČ chain of haemoglobin.
Types of thalassaemias
1. α-Thalassaemia (α-globin chain is impaired)
2. ÎČ-Thalassaemia (ÎČ-globin chain is impaired).
3. ÎŽ-Thalassaemia (ÎŽ-globin chain is impaired).
ÎČ-Thalassaemia
‱ ÎČ-Thalassaemia is a result of several different
molecular defect.
‱ Over 100 mutations have been described that
result in partial to complete absence of ÎČ-gene
expression.
‱ ÎČ- Thalassaemia rarely can be due to deletion
of structural gene.
ÎČ-Thalassaemia
‱ Mutation may affect any step in the pathway of
globin gene expression including gene
transcription, RNA processing of m-RNA
translation, and post-translation integrity of the
protein.
‱ Two types of abnormal genes (ÎČthal )are
designed ÎČ0 and ÎČ+).
Classification of ÎČ- Thalassaemia
‱ Previously, thalassaemia were commonly
classified according to clinical severity of the
disease into:
-Thalassaemia major (Cooley's anaemia)
-Thalassaemia intermedia
- Thalassaeia minor
Classification of ÎČ-Thalassaemia
‱ Genotypic classification into:
‱ Homozygous ÎČ- Thalassaemia (ÎČ0 ÎČ0 , ÎČ+ ÎČ+).
‱ Heterozygous (ÎČ ÎČ0 or ÎČ ÎČ+, ÎČ0  ÎČ+).
Classification & Terminology
ÎČ-Thalassemia
‱ Normal b/b
‱ Minor b/b0
b/b+
‱ Intermedia b0/b+
‱ Major b0/b0
b+/b+
Pathophysiology
‱ Normally equal quantities of α- and ÎČ- are
synthesized by maturing erythrocyte.
‱ IN ÎČ-Thalassaemia, synthesis of ÎČ- chains
is deceased or absent, resulting in an
excess of free alpha chains.
Pathophysiology
‱ This imbalance synthesis of Beta and alpha
has several effects:
1. Decrease in total erythrocyte haemoglobin
production
2. Ineffective erythropoiesis
3. Chronic haemolytic process
Homozygous ÎČ-Thalassaemia
‱ This disorder is caused by marked reduction or
absence of ÎČ- chains.
‱ Clinical finding:
1- The general signs of anaemia.
2- Heart failure
3- Growth retardation and skin pigmentation.
4- gout and gallstone
5- spleenomegally
6- bone changes and bossing of the skull
7- Iron over load develop due to repeated transfusion
Laboratory diagnosis
‱ Hb may be low as 2 to 3 g/dl.
‱ MCV,MCH,MCHC are also markedly deceased.
‱ The cord blood normally has 20% of Hb A.
‱ The cord blood of infant with Thalassaemia has
less than 2% Hb A.
‱ Peripheral blood picture shows anisocytosis,
poikelocytosis, schistocytes, nucleated red cells,
target cells, polychromasia.
Laboratory diagnosis
- Haemoglobin electrophoresis show absence of
Hb A increase in Hb A2 and Hb F (90%) is
characteristic of ÎČ0 ÎČ0 .
- The other homozygous ÎČ+ ÎČ+, show HbA (24%
to 36 %).
Haemoglobin analysis by Hb
electrophoresis
Types of Haemoglobin:
‱ HbA:a2b2
‱ Hb A2: a2d2
‱ HbF:a2g2
‱ Embryonic Hb: Portland z2g2
‱ Hb Bart’s: g4
‱ Hb H: b4
Thalassemia Major:
Partial or lack of HbA synthesis ↓MCHC &
MCH Hypochromia & microcytosis
Normal
Thalassaemia
Reticulocytes undergo intramedullary death
Inadequate production + ineffective erythropoiesis
+ haemolysis Anaemia
↑Haemolysis ↑demands of phagocytic function
 hyperplasia of phagocytes
Hepatosplenomegaly
To compensate anaemia extramedullary
haemopoiesis in liver, spleen & brain
Organomegaly
↑Erythropoiesis marrow expansion & thinning
of cortex of skull bone Thalassaemia facies
Heterozygous ÎČ- Thalassaemia
The heterozygous state of ÎČ- Thalassaemia
(Thalassaemia minor) results from the inheritance
of either ÎČ+ or ÎČo Thalassaemia gene and one
normal ÎČ-gene is present. The normal gene directs
the synthesis of ÎČ-gene and the erythrocyte survival
is nearly normal.
The heterozygote disorder appears
symptomless except in periods of stress and
pregnancy when moderate microcytic anaemia
develops.
‱The anaemia is mild with Hb 9 to 11 mg/dl
‱The RBCs is double for what expected at that Hb
con.
‱The cord blood of infant has 6 % to 10% HbA
‱The cells are microcytic (MCV 55 to70 fl)
‱The peripheral blood smear shows variable
Anisocytosis and poikelocytosis target cells and
basophilic stippling.
Lab. Diagnosis
Bone marrow shows erythroid hyperplasia and
normoblast poorly filled with haemoglobin.
* Haemoglobin electrophoresis demonstrate Hb
A2 from 5 to 7% with a mean of 5.5.
* Hb F may be normal or increased.
* The blood picture is similar to that of iron
deficiency anaemia.
α-Thassaemia
An absence or deficiency of α-chain synthesis due
to deletion of α-genes.
In normal individual HbA, HbA2 and HbF need α-
chain for their formation.
4 genes of α-chain, each pair on short arm of
chromosome 16 present with genotype α,α/α,α.
In α-thalassaemia, deletion of α-genes reduction
or absence of synthesis of α-chain depending on
number of α-gene deletion.
Pathogenesis of α-Thalassaemia
‱ ↓α-chain synthesis free Îł-chain in the
fetus & ÎČ-chain in infant of 6 months, and
continue in the rest of life.
‱ Complementary 4Îł and 4ÎČ are aggregated
 Hb Bart (4Îł ) and HbH (4ÎČ ),
respectively.
Variants of α-Thalassaemia
‱ Silent carrier
– Deletion of single α-gene
– Genotype α/αα
– Asymptomatic
– Absence of RBC abnormality
‱ Thalasaemia trait
– Deletion of 2 α-genes
– Genotype --/αα
– Asymptomatic, minimal or no anaemia
– Minimal RBC abnormalities
‱ Hb H disease
– Deletion of 3 α-genes
– Genotype --/- α
– 75% reduction of α-chain
– 25% α-chain synthesis small amount of HbF, HbA,
& HbA2
– Fetus can survive
– Severe anaemia
– Severe RBC abnormalities
‱ Hydrops fetalis
– Deletion of all α-genes
– Genotype --/--
– Absence of α-chain synthesis
– Only Hb Bart (γ4) is produced (High affinity for O2
and can not dissociate O2 to tissue)
High oxygen affinity-hypoxia instability of homotetramers inclusion
bodies. Membrane damage shortened red cell survival - haemolysis
spleenomegaly – hypersplenism.
The pathophysiology of α thalassaemia
Hb H
‱ Hb H is an unstable , thermolabile protein with
an oxygen affinity 10 times that of Hb A.
‱ Because is an unstable Hb it precipitate chronic
haemolytic process.
‱ Hb H is particularly sensitive to oxidation,
forming intracellular precipitate in older cells.
‱ The life span shortened as these inclusions
injure the cell membrane.
Terminology
a+ one gene on one chromosome is
inactivated.
a0 both genes on one chromosome are
inactivated.
The genetics of α-thalassaemia
α-Thalassaemia: hydrops fetalis
‱ α-Thalassaemia: haemoglobin H disease (three α-globin
gene deletion). The blood film shows marked hypochromic,
microcytic cells with target cells and poikilocytosis
Reticulocyte
Hb H
Acquired haemolytic anaemias
Immune haemolytic anaemias
Non-immune haemolytic anaemias
Classification of acquired HA
Acquired HA
– Immune
-Autoimmune eg AIHA
-Alloimmune e.g HDN, HTR
-drug induced immune HA e.g methyl dopa
– Red cell fragmentation syndromes
– March haemoglobinuria
– Infections
– Chemical and physical agents.
– PNH
Immune HA
Autoimmune HA ( AIHA)
‱ These are caused by antibody
production by the body itself against its
own red cells.
‱ It is divided into warm and cold types
according to whether the antibody
reacts more strongly with red cells at
37O C or 4O C.
AIHA classification
Warm type
‱ Idiopathic
‱ Secondary
‱ SLE, other
autoimmune
diseases
‱ CLL, lymphomas
‱ Drugs
Cold type
‱ Idiopathic
‱ Secondary
‱ Infections-
Mycoplasma
pneumonia,
Infectious
mononucleosis.
‱ Lymphoma
‱ Paroxysmal cold
haemoglobinuria.
Laboratory findings in warm AIHA
‱ Haematological and biochemical
findings of extravascular haemolysis
with spherocytosis prominent in the
peripheral blood.
‱ Direct antiglobulin test is positive
(Coombs test) as a result of IgG, IgG
and complement or IgA on the cells.
Warm AIHA
‱ anaemia, spherocytes
and polychromatic
macrocytes. The
blood film in this
condition occasionally
shows small red cell
agglutinates.
Cold AIHA
‱ The antibody attaches to red cells mainly in
the peripheral circulation where the blood
temperature is cooled.
‱ The AB is usually IgM and binds to red cells
at 4o C.
‱ IgM antibodies are highly efficient in fixing
complement.
‱ Both intravascular and extravascular
haemolysis can occur.
Laboratory findings in cold AIHA
‱ Similar to those of warm AIHA, except
that spherocytosis is less marked.
‱ Red cells agglutinate in the cold.
‱ DAT reveals complement (C3d) only on
the red cell surface.( the AB having
eluted off the cells in warmer parts of
the circulation).
Cold agglutinins
‱ very large red cell
agglutinates form on
spreading the blood film and
and an abnormality can be
appreciated on
macroscopic inspection of the
blood film.
The nature of the abnormality
can be confirmed by
microscopic examination. If
the blood is warmed before
spreading, the degree of
abnormality is much less.
Cold AIHA
‱ Red cell clumping in
cold AIHA
Alloimmune HA
‱ In these anaemias, antibody produced
by one individual reacts with red cells of
another.
‱ Two important conditions
– Transfusion of ABO incompatible blood
– Rhesus disease of the newborn
Rh-HDN
‱ Blood film in rhesus
haemolytic disease
of the newborn
showing several
spherocytes.
Non immune HA
Red cell fragmentation syndromes
‱ They arise through physical damage to
red cells on abnormal surfaces.
– Artificial heart valves or arterial grafts.
– Malignant hypertension
– Haemolytic uraemic syndrome

.
Mechanical HA (red cell fragmentation
syndrome)
‱ There are
macrocytes
and red cell
fragments.
Non immune HA
Infections
‱ Malaria causes haemolysis by
extravascular destruction of parasitised
red cells as well as intravascular
haemolysis accompanied by acute renal
failure caused by Falciparum malaria.
‱ Clostridium perfringens  intravascular
haemolysis.
P.vivax
‱ Blood film in P. vivax
malaria.World-wide,
malaria is a very
common cause of
haemolytic anaemia.
Blood film in P. falciparum malaria
a very heavy
parasitaemia with
numerous ring forms
and one early
gametocyte. World-
wide,malaria is a very
common cause of
haemolytic anaemia. P.
falciparum can cause
acute intravascular
haemolysis leading to
'blackwater fever'.
Clostridium perfringens sepsis
‱ . The blood film shows
severe anaemia and
marked spherocytosis.
The spherocytosis is
consequent on direct
damage to the red cell
membrane by a
bacterial toxin.
Non-immune HA
Chemical and physical agents
- Certain drugs as dapsone and
salazopyrine can cause oxidative
intravascular haemolysis.
- Severe burns damage red cells causing
spherocytosis or acanthocytosis.
Burns
‱ spherocytes and
microspherocytes..
There may also be a
'packed film'
consequent on elevation
of the Hb as a result of
loss of plasma into
burnt tissues. A film as
abnormal as this is
usually associated with
burns that are so severe
that they are fatal.
Non-immune HA
Paroxysmal nocturnal haemoglobinuria
(PNH)
‱ This is a rare, acquired, clonal disorder
‱ The red cells are sensitive to lysis by
complement and the result is chronic
intravascular haemolysis.
Pathophysiology of PNH
‱ PNH is a rare, acquired disorder of marrow
stem cells in which there is deficient
synthesis of the glycosylphosphatidyl inositol
(GPI) anchor,(a structure that attaches
several surface proteins to the cell
membrane).
Cont

‱ It results from mutations in the X chromosome
gene coding for phosphatidyl inositol glycan
protein A (PIG-A) which is essential for the
formation of the GPI anchor.
‱ GPI-linked proteins (such as CD55 and CD59)
are absent from the abnormal stem cell surface
of all the cells.
Cont

‱ These proteins, CD59 or membrane inhibitor of
reactive lysis (MIRL) and CD55 or decay
accelerating factor (DAF), protects the red cell
from being lysed by the membrane attack complex
(C5–C8) that forms when complement (C) is
activated and the result is chronic intravascular
haemolysis.
Cont

‱ Chronic intravascular haemolysis in PNH is
probably explained by activation of C through
the „alternative‟ pathway
‱ CD55 and CD59 are also present on white cells
and platelets.
‱ In addition to haemolytic anaemia, the patient
may have thrombosis and pancytopenia.
Clinical features
1. Haemoglobinuria due to intravascular haemolysis
2. Haemolytic anaemia with a low platelet and/or
low neutrophil count
3. Haemolytic anaemia and recurrent abdominal
pain with or without blood in the stool.
4. Hepatic vein thrombosis (Budd–Chiari syndrome)
5. Any venous thrombosis anywhere in young adult
with low platelet and/or the neutrophil counts.
6. Idiopathic pancytopenia (IAA).
Laboratory findings and
diagnosis
Diagnosis of PNH
‱ Haemoglobinuria
‱ Haemosidrinuria
‱ Ham‟s test is positive in PNH. It shows
red cell lysis in serum at low pH
‱ Flow cytometry to look for the loss of
expression of GPI-linked proteins such as
CD55 and CD59.
Thank you

Haemolytic anaemias types and causes-1.pdf

  • 1.
  • 2.
    Haemolytic anaemias (HAs) ‱HAs are defined as those anaemias which result from an increase in the rate of red cell destruction.
  • 3.
    ‱ Because oferythropoietic hyperplasia and anatomical extension of bone marrow, red cell destruction may be increased several fold before the patient become anaemic --- compensated haemolytic anaemia. ‱ The normal adult marrow, after full expansion, is able to produce red cells at 6-8 times the normal rate.
  • 4.
    Classification of HA ‱The HA can be classified in several different ways: 1- Site of haemolysis: ‱ Extravascular haemolytic disorders - macrophages of the RES ‱ Intravascular haemolytic disorders- within the circulatory system ‱ In many of the cases there is a combination of both extra and intravascular haemolysis.
  • 5.
    Extravascular haemolysis ‱ Redcell destruction usually occurs in the cell of the RES.
  • 6.
    Intravascular haemolysis ‱ Destructionof red cells occur inside the blood vessels.
  • 7.
    Cont
. 2- Site ofdefect: ‱ Intrinsic defect (intracorpuscular)- structural or functional defect within the red cell. ‱ Extrinsic defect (extracorpuscular)- an abnormality in the red cell environment.
  • 8.
    Cont
 3- Inherited oracquired: ‱ Inherited HA are usually caused by intrinsic defect. ‱ While acquired HA are caused by an extrinsic defect. ‱ However there are some exceptions: Paroxysmal nocturnal haemoglobinuria (PNH) which is an acquired intrinsic defect, and severe hereditary G6PD enz deficiency which requires the presence of an extrinsic trigger such as the antimalarial drug for the intrinsic defect to manifest.
  • 9.
    Inherited & acquiredHA Hereditary HA ‱ Membrane defects e.g hereditary spherocytosis ‱ Metabolic defect e.g G6PD deficiency. ‱ Haemoglobin defects e.g sickle cell disease. Acquired HA – Immune -Autoimmune eg AIHA -Alloimmune e.g HDN, HTR – Red cell fragmentation syndromes – March haemoglobinuria – Infections – Chemical and physical agents. – PNH
  • 10.
    Approach to thediagnosis of haemolytic anaemias.
  • 11.
    Patient’s history ‱ Goodhistory is essential to provide guidance for the diagnosis of haemolytic disorders. The following points should not be neglected: ‱ Family history--- hereditary conditions, mode of inheritance. ‱ Ethnic origin--- G6PD deficiency is most common in Mediterranean and Chinese populations. ‱ Past history--- Neonatal jaundice may be indicative of congenital conditions as HS or G6PD deficiency. ‱ Triggering events--- history of drugs, infections
  • 12.
    Clinical features ‱ Pallorof the mucous membranes ‱ Mild fluctuating jaundice ‱ Splenomegaly ‱ Dark urine ‱ Pigment gall stones. ‱ Ulcers around the ankle ‱ Aplastic crisis may complicate viral infections. ‱ Growth retardation ‱ Hypertrophic skeletal changes
  • 13.
    ‱ Leg ulcersin patients with severe congenital haemolytic disorders. e.g sickle cell anaemia
  • 14.
    ‱ Skeletal changesin patients with b thalassaemia.
  • 15.
    Laboratory findings ‱ Thelab. Findings are divided into 3 groups: 1- Features of increased red cell breakdown. 2- Features of increased red cell production. 3- Damaged red cells.
  • 16.
    Laboratory findings 1-Features ofincreased red cell breakdown: ‱ Raised S.bilirubin, unconjugated and bound to albumin. ‱ Increased urine urobilinogen. ‱ Increased faecal stercobilinogen. ‱ Absent S.haptoglobins (saturated with Hb and removed by the RE cells).
  • 17.
    Laboratory findings 2-Features ofincreased red cell production: ‱ Reticulocytosis ‱ Bone marrow erythroid hyperplasia.
  • 18.
    Laboratory findings ‱ 3-Damagedred cells: ‱ Morphology– microspherocytes, elliptocytes, fragments, etc.,
. ‱ Special tests: Osmotic fragility, autohaemolysis
.. ‱ Red cell survival is shortened; this is best shown by 51Cr labelling with study of the sites of destruction.
  • 21.
    ‱ Reticulocytosis isa feature of increased red cell production. ‱ New methylene blue is used to stain the reticulocytes
  • 22.
    ‱ Fragmented cells, andbitten cells are sings of damaged cells occurring in haemolysis
  • 23.
  • 24.
    Intravascular haemolysis ‱ FreeHb will be released from damaged red cells. ‱ This free Hb will rapidly saturates plasma haptoglobins. The complex will be removed by the liver. ‱ The excess free Hb is filtered by the glomerulus, and free Hb will enter the urine, as iron is released, the renal tubules become loaded with haemosiderin. ‱ Methaemalbumin and haemopexin are also found in the process of IV haemolysis.
  • 25.
    ‱ The processof intravascular haemolysis ‱ Liberation of free Hb ‱ Filtered through the kidney ‱ Appear in urine as haemoglobinuria
  • 26.
    Lab features ofintravascular haemolysis ‱ Haemoglobinaemia & haemoglobinuria. ‱ Haemosiderinuria (iron storage protein in the spun deposit of urine). ‱ Methaemalbumin (detected by Schumm‟s test).
  • 27.
    Haemoglobinuria ‱ Notice thedark colour of urine compared to the normal colour in the other container. ‱ This is a sign of intravascular haemolysis.
  • 28.
    Conclusion ‱ Good historytaking is essential in guiding the physician towards the correct diagnosis. ‱ Clinical findings seldom are sufficient to enable a definitive diagnosis of a particular haemolytic condition to be made. ‱ Lab investigations play a central role in the accurate diagnosis of haemolysis.
  • 29.
  • 30.
    Hereditary haemolytic anaemias ‱Membrane defects – congenital spherocytosis ‱ Metabolic defects – G6PD enzyme deficiency ‱ Haemoglobin defects – Qualitative defects – sickle cell anaemia – Quantitative defects – Thalassaemia
  • 32.
  • 35.
    The clinical phenotypesof hereditary membrane disorders The mutations affecting the red cell membrane are many, but the effect on the phenotype can be classified into 5 main categories. ‱ Hereditary spherocytosis ‱ Hereditary elliptocytosis and Hereditary pyropoikilocytosis ‱ South-East Asian ovalocytosis ‱ Hereditary acanthocytosis ‱ Hereditary stomatocytosis
  • 36.
    Hereditary spherocytosis (HS) ‱It is the most common hereditary haemolytic anaemia in North Europeans. ‱ The prevalence is 200-300 per million in the population (European population).
  • 37.
    Pathogenesis of HS ‱It is caused by a defect in the proteins involved in the interactions between the membrane cytoskeleton and the lipid bilayer of the red cell. ‱ About 60% of HS cases result from a defect in the ankyrin-spctrin complex. ‱ A further 25% involve deficiency in band 3, the anion channel. ‱ In the remainder, there is a deficiency of protein 4.2 or no abnormality detected.
  • 38.
    Clinical features ‱ Theinheritance is autosomal dominant. ‱ Rarely it may be autosomal recessive. ‱ The anaemia may present at any age from infancy to old age. ‱ Jaundice is fluctuating. ‱ HS is also called “familial acholuric jaundice” emphasizing the presence of jaundice in absence of bile in urine. ‱ Splenomegaly occurs in most of the patients. ‱ Pigment gall stones are frequent.
  • 39.
    Haematological findings inHS ‱ Features of extravascular haemolysis are present. ‱ Anaemia is usual. ‱ Reticulocytosis 5-20% ‱ Microspherocytes are seen in the blood film. (densely staining with smaller diameters than normal red cells).
  • 41.
  • 42.
    Other investigations ‱ Theclassic finding is that the osmotic fragility is increased in HS with a shift of the curve to the right. ‱ Autohaemolysis is increased and corrected by glucose. ‱ Direct antiglobulin test (Coombs test) is normal.
  • 44.
    Autohaemolysis test inHS There is increased haemolysis in the patient in comparison with the control. Glucose has given partial correction.
  • 45.
    Treatment ‱ Patients withwell-compensated haemolysis and no transfusion requirements need no treatment other than reassurance and folic acid supplements. ‱ The principal form of treatment is splenectomy although this should not be performed unless clinically indicated because of the risk of post-splenectomy sepsis, particularly in early childhood.
  • 46.
    Hereditary elliptocytosis (HE) ‱HE is inherited as an autosomal-dominant trait except for a rare Melanesian type that inherited as a recessive trait. The disorder occurs in all racial groups with an occurrence of .02% to 0.05%. ‱ The disease is heterogeneous in the degree of haemolysis and clinical severity. The prominent peripheral blood finding is an increase in oval and elongated cells (elliptocytes).
  • 47.
    Pathophysiology ‱ The principaldefect involves horizontal membrane interactions. 1) Decreased association of Spectrin dimmers to form tetramers due to defective spectrin chains. 2) Deficiency or defective in band 4.1 which aids in binding spectrin to actin. 3) Defective association of spectrin – ankyrin due to spectrin chains mutants.
  • 48.
    Pathophysiology ‱ Each ofthese defects can lead to skeletal disruptions that can cause the cell to become elliptical in shape and/or fragment under the stresses of circulation depending on the extent of the defect. ‱ Mildly dysfunction proteins cause only elliptocytosis ; whereas, severely dysfunctional proteins cause membrane fragmentation in addition to elliptocytosis.
  • 49.
    Pathophysiology ‱ Elliptocytosis withmembrane fragmentation causes decrease in cell surface area and reduced cells deformability. ‱ The lifespan of these cells is severely shortened. ‱ HE erythrocytes are abnormally permeable to Na+. ‱ This altered permeability demands an increase in ATP to maintain osmotic equilibrium. ‱ In the spleen the cell quickly deplete their ATP and become osmotically fragile.
  • 50.
    Clinical finding ‱ Ninetypercent of patients with HE show no signs of haemolysis. ‱ Patients have compensated haemolytic disease. ‱ Anaemia is not characteristic.
  • 51.
    Lab- finding ‱ Themost consistent and characteristic lab finding in all variants is prominent elliptocytosis. Haemoglobin levels are usually greater than 12 g/l. ‱ Reticulocytes are mildly elevated to 4%. ‱ In HE variant haemoglobin is 9 to 10 g/dl, and reticulocyte are elevated to 20%. ‱ Microelliptocyte, schistocytes, and spherocytes are usually evidence. ‱ Bone marrow show erythroid hyperplasia with normal maturation.
  • 52.
    Hereditary stomatocytosis ‱ Itis a rare autosomal-dominant haemolytic anaemia in which the erythrocyte membrane is abnormally permeable to both Na+ and K+. ‱ As a result, the intracellular concentration of cations increases, water inters the cell, and the overhydrated cells take on the appearance of stomatocytes. ‱ Stomatocytes on dried stained blood films are erythrocytes with a slit-like (mouth-like) area of pallor.
  • 53.
    Pathophysiology ‱ The stomatocytescells are osmotically fragile and less deformable than normal cells and as a result the cells are sequestered in the spleen and phagocytosed.
  • 54.
    Lab. Finding ‱ Anemiais usually mild (8 to 10 g/dl). ‱ Bilirubin is increased. ‱ Reticulocytosis is moderate. ‱ The blood film is remarkable for 10 to 50% stomatocytes. ‱ Osmotic fragility and autohaemolysis are increased. ‱ Autohaemolysis is partially corrected with glucose and ATP.
  • 55.
    Lab. finding ‱ Inheritedstomatocytosis must be differentiated from acquired causes of stomatocytosis. ‱ Stomatocytosis also are seen in an acquired defect in acute alcoholism, liver disease, and cardiovascular disease. ‱ In these acquired conditions there is no cation leaks, and little haemolysis is present.
  • 56.
    South-East Asian ovalocytosis ‱This is common in Malaysia, Indonesia and the Philippines. ‱ It is due to Band 3 protein abnormality. ‱ The cells are rigid and resist invasion by malaria parasite. ‱ Most cases are asymptomatic.
  • 57.
    Blood film inhereditary stomato- ovalocytosis ‱ basophilic stippling and numerous stomatocytes.
  • 58.
    Defective red cellmetabolism G6PD enzyme deficiency Pyruvate kinase deficiency
  • 59.
    ‱ G6PD functionsto reduce nicotinamide adenine dinucleotide phosphate (NADPH) while oxidizing glucose-6- phosphate. ‱ NADPH is needed for the production of reduced glutathione (GSH) which is important to defend the red cells against oxidant stress.
  • 60.
    G6PD deficiency ‱ Morethan 400 variants due to point mutations or deletions of the enzyme G6PD have been characterized which show less activity than normal. ‱ Worldwide over 400 million people are G6PD deficient in enzyme activity.
  • 61.
    Clinical features There arefour main syndromes associated with G6PD enzyme deficiency. ‱ Neonatal jaundice (class I,II,III) ‱ Favism (class II) ‱ Chronic non spherocytic haemolytic anaemia (CNSHA) (class I) ‱ Drug induced haemolytic anaemia (class III)
  • 62.
    G6PD deficiency ‱ Theinheritance is sex-linked, affecting males, and carried by females. ‱ The main races affected are in West Africa, the Mediteranean, the Middle East, and South East Asia.
  • 63.
    Lab Diagnosis ‱ Betweencrises blood count is normal. ‱ The enzyme deficiency is detected by – One of a number of screening tests or – By direct enzyme assay on red cells. ‱ During the crisis, the blood film may show contracted and fragmented cells, bite and blister cells. ‱ Enzyme assay may give a false normal level in the phase of acute haemolysis. ‱ There are features of intravascular haemolysis.
  • 64.
    G6PD deficiency ‱ Theblood film shows irregularly contracted cells [deep red arrows] and sometimes hemighosts [deep blue arrow] in which all the haemoglobin appears to have retracted to one side of the erythrocyte.
  • 65.
    Management ‱ Education inthe avoidance of oxidising substances is important ‱ The offending drug is stopped. ‱ Any underlying infection is treated. ‱ High fluid intake is encouraged to avoid renal failure. ‱ Blood transfusion, if necessary, for severe anaemia.
  • 66.
    Pyruvate kinase deficiency Deficiencyof glycolytic enzymes ‱ Most common after G6PD def – Deficient ATP production, chronic haemolytic anemia ‱ Autosomal recessive - Rare [prevalence 1/10,000] Clinical features ‱ Most are jaundice and anemic infancy and childhood ‱ Occasional mild diagnosed only in adulthood ‱ Hydrops fetalis ‱ Compensated haemolytic anemia ‱ Neonatal jaundice ‱ Gallstone ‱ Frontal bossing
  • 67.
    Lab finding ‱ Severityof anaemia varies widley (4 – 10 g/dl). ‱ P. Smear: poikilocytosis prikle cells contracted RBCs with spicules. ‱ Direct enzyme assay (decreased enzyme activity) ‱ Rise of intracellular 2,3-DPG (reduce severity) ‱ Autohaolysis increased not corrected by glucose as in HS.
  • 68.
  • 69.
    Haemoglobinopathies: ‱Sickle cell anaemia. ‱Thalassaemias. ‱HaemoglobinC disease. ‱Haemoglobin S/C disease. ‱Haemoglobin D (Punjab, Los Angelos). ‱Haemoglobin E. ‱Unstable haemoglobin.
  • 71.
  • 72.
    Defective haemoglobin Sickle cellanaemia ‱ It is group of haematological disorders results from single base change in the DNA coding for the amino acid in the sixth position in the b- globin chain. This leads to an amino acid change from glutamic acid to valine  HbS will be formed instead of the normal Hb.
  • 73.
    Sickle cell anaemia ‱Hb S is insoluble and forms crystals when exposed to low oxygen tension. ‱ Deoxygenated sickle Hb polymerizes into long fibrils. ‱ The red cells sickle and may block the different areas of the microcirculation or large vessels causing infarcts of various organs. ‱ It is widespread in West Africa.
  • 74.
    Classification ‱ Sickle celltrait (heterozygote). ‱ Sickle cell disease (homozygote).
  • 75.
  • 76.
    Clinical finding insickle cell disease ‱ Vaso-occlusitve crisis lead to infarction in several organs such as bones, lung, spleen and brain. ‱ Visceral sequestration crises eg. Sickle chest syndrome. ‱ Aplastic crises due to infection or folate def. sudden fall in Hb. ‱ Haemolytic crises increase rate of haemolysis with fall in Hb and accompany by painful crises. ‱ Leg ulcer. ‱ Leg hand syndrome. ‱ Spleen enlargement.
  • 77.
    Laboratory findings ‱ Hbis usually 6-9 g/dl. ‱ Sickle cells and target cells occur in the blood. ‱ Screening tests for sickling are positive. ‱ Hb electrophoresis in Hb SS, no Hb A is detected. The amount of Hb F is variable 5- 15%.
  • 78.
  • 79.
    Sickle cell trait ‱Sickle cell trait is heterozygous ÎČs state (HbAS). ‱ The patient has one normal ÎČ-gene and one abnormal ÎČs –gene . ‱ Hb A constitute more than 50% of total Hb in these individuals so there is no clinical symptoms . ‱ Complication of splenic infarction is possible if the affected individuals exposed to prolong hypoxia.
  • 80.
    Other Sickling Disorders Othertypes of Hb combine with sickle Hb 2. Hemoglobin S-C disease – Sickle haemoglobin (HbS) + (HbC) 3. Hemoglobin S-Beta thalassemia – Beta thalassaemia gene reduces the amount of HbA that can be made – Sickle haemoglobin (HbS) + reduced HbA – Milder form of Sickle Cell Disorder than sickle cell anemia
  • 81.
  • 82.
    Definition ‱ Thalassaemias areheterogeneous group of genetic disorders due to mutation that causes decrease in the rate of synthesis of one of the constituent globins chains ,usually α or ÎČ chain of haemoglobin.
  • 83.
    Types of thalassaemias 1.α-Thalassaemia (α-globin chain is impaired) 2. ÎČ-Thalassaemia (ÎČ-globin chain is impaired). 3. ÎŽ-Thalassaemia (ÎŽ-globin chain is impaired).
  • 84.
    ÎČ-Thalassaemia ‱ ÎČ-Thalassaemia isa result of several different molecular defect. ‱ Over 100 mutations have been described that result in partial to complete absence of ÎČ-gene expression. ‱ ÎČ- Thalassaemia rarely can be due to deletion of structural gene.
  • 85.
    ÎČ-Thalassaemia ‱ Mutation mayaffect any step in the pathway of globin gene expression including gene transcription, RNA processing of m-RNA translation, and post-translation integrity of the protein. ‱ Two types of abnormal genes (ÎČthal )are designed ÎČ0 and ÎČ+).
  • 86.
    Classification of ÎČ-Thalassaemia ‱ Previously, thalassaemia were commonly classified according to clinical severity of the disease into: -Thalassaemia major (Cooley's anaemia) -Thalassaemia intermedia - Thalassaeia minor
  • 87.
    Classification of ÎČ-Thalassaemia ‱Genotypic classification into: ‱ Homozygous ÎČ- Thalassaemia (ÎČ0 ÎČ0 , ÎČ+ ÎČ+). ‱ Heterozygous (ÎČ ÎČ0 or ÎČ ÎČ+, ÎČ0 ÎČ+).
  • 88.
    Classification & Terminology ÎČ-Thalassemia ‱Normal b/b ‱ Minor b/b0 b/b+ ‱ Intermedia b0/b+ ‱ Major b0/b0 b+/b+
  • 89.
    Pathophysiology ‱ Normally equalquantities of α- and ÎČ- are synthesized by maturing erythrocyte. ‱ IN ÎČ-Thalassaemia, synthesis of ÎČ- chains is deceased or absent, resulting in an excess of free alpha chains.
  • 92.
    Pathophysiology ‱ This imbalancesynthesis of Beta and alpha has several effects: 1. Decrease in total erythrocyte haemoglobin production 2. Ineffective erythropoiesis 3. Chronic haemolytic process
  • 93.
    Homozygous ÎČ-Thalassaemia ‱ Thisdisorder is caused by marked reduction or absence of ÎČ- chains. ‱ Clinical finding: 1- The general signs of anaemia. 2- Heart failure 3- Growth retardation and skin pigmentation. 4- gout and gallstone 5- spleenomegally 6- bone changes and bossing of the skull 7- Iron over load develop due to repeated transfusion
  • 94.
    Laboratory diagnosis ‱ Hbmay be low as 2 to 3 g/dl. ‱ MCV,MCH,MCHC are also markedly deceased. ‱ The cord blood normally has 20% of Hb A. ‱ The cord blood of infant with Thalassaemia has less than 2% Hb A. ‱ Peripheral blood picture shows anisocytosis, poikelocytosis, schistocytes, nucleated red cells, target cells, polychromasia.
  • 95.
    Laboratory diagnosis - Haemoglobinelectrophoresis show absence of Hb A increase in Hb A2 and Hb F (90%) is characteristic of ÎČ0 ÎČ0 . - The other homozygous ÎČ+ ÎČ+, show HbA (24% to 36 %).
  • 96.
    Haemoglobin analysis byHb electrophoresis Types of Haemoglobin: ‱ HbA:a2b2 ‱ Hb A2: a2d2 ‱ HbF:a2g2 ‱ Embryonic Hb: Portland z2g2 ‱ Hb Bart’s: g4 ‱ Hb H: b4
  • 97.
  • 98.
    Partial or lackof HbA synthesis ↓MCHC & MCH Hypochromia & microcytosis Normal Thalassaemia
  • 99.
    Reticulocytes undergo intramedullarydeath Inadequate production + ineffective erythropoiesis + haemolysis Anaemia
  • 100.
    ↑Haemolysis ↑demands ofphagocytic function  hyperplasia of phagocytes Hepatosplenomegaly To compensate anaemia extramedullary haemopoiesis in liver, spleen & brain Organomegaly
  • 101.
    ↑Erythropoiesis marrow expansion& thinning of cortex of skull bone Thalassaemia facies
  • 102.
    Heterozygous ÎČ- Thalassaemia Theheterozygous state of ÎČ- Thalassaemia (Thalassaemia minor) results from the inheritance of either ÎČ+ or ÎČo Thalassaemia gene and one normal ÎČ-gene is present. The normal gene directs the synthesis of ÎČ-gene and the erythrocyte survival is nearly normal.
  • 103.
    The heterozygote disorderappears symptomless except in periods of stress and pregnancy when moderate microcytic anaemia develops.
  • 104.
    ‱The anaemia ismild with Hb 9 to 11 mg/dl ‱The RBCs is double for what expected at that Hb con. ‱The cord blood of infant has 6 % to 10% HbA ‱The cells are microcytic (MCV 55 to70 fl) ‱The peripheral blood smear shows variable Anisocytosis and poikelocytosis target cells and basophilic stippling. Lab. Diagnosis
  • 105.
    Bone marrow showserythroid hyperplasia and normoblast poorly filled with haemoglobin. * Haemoglobin electrophoresis demonstrate Hb A2 from 5 to 7% with a mean of 5.5. * Hb F may be normal or increased. * The blood picture is similar to that of iron deficiency anaemia.
  • 106.
    α-Thassaemia An absence ordeficiency of α-chain synthesis due to deletion of α-genes.
  • 107.
    In normal individualHbA, HbA2 and HbF need α- chain for their formation. 4 genes of α-chain, each pair on short arm of chromosome 16 present with genotype α,α/α,α. In α-thalassaemia, deletion of α-genes reduction or absence of synthesis of α-chain depending on number of α-gene deletion. Pathogenesis of α-Thalassaemia
  • 108.
    ‱ ↓α-chain synthesisfree Îł-chain in the fetus & ÎČ-chain in infant of 6 months, and continue in the rest of life. ‱ Complementary 4Îł and 4ÎČ are aggregated  Hb Bart (4Îł ) and HbH (4ÎČ ), respectively.
  • 109.
    Variants of α-Thalassaemia ‱Silent carrier – Deletion of single α-gene – Genotype α/αα – Asymptomatic – Absence of RBC abnormality ‱ Thalasaemia trait – Deletion of 2 α-genes – Genotype --/αα – Asymptomatic, minimal or no anaemia – Minimal RBC abnormalities
  • 110.
    ‱ Hb Hdisease – Deletion of 3 α-genes – Genotype --/- α – 75% reduction of α-chain – 25% α-chain synthesis small amount of HbF, HbA, & HbA2 – Fetus can survive – Severe anaemia – Severe RBC abnormalities ‱ Hydrops fetalis – Deletion of all α-genes – Genotype --/-- – Absence of α-chain synthesis – Only Hb Bart (Îł4) is produced (High affinity for O2 and can not dissociate O2 to tissue)
  • 111.
    High oxygen affinity-hypoxiainstability of homotetramers inclusion bodies. Membrane damage shortened red cell survival - haemolysis spleenomegaly – hypersplenism. The pathophysiology of α thalassaemia
  • 112.
    Hb H ‱ HbH is an unstable , thermolabile protein with an oxygen affinity 10 times that of Hb A. ‱ Because is an unstable Hb it precipitate chronic haemolytic process. ‱ Hb H is particularly sensitive to oxidation, forming intracellular precipitate in older cells. ‱ The life span shortened as these inclusions injure the cell membrane.
  • 113.
    Terminology a+ one geneon one chromosome is inactivated. a0 both genes on one chromosome are inactivated.
  • 114.
    The genetics ofα-thalassaemia
  • 115.
  • 116.
    ‱ α-Thalassaemia: haemoglobinH disease (three α-globin gene deletion). The blood film shows marked hypochromic, microcytic cells with target cells and poikilocytosis
  • 117.
  • 118.
  • 119.
    Acquired haemolytic anaemias Immunehaemolytic anaemias Non-immune haemolytic anaemias
  • 120.
    Classification of acquiredHA Acquired HA – Immune -Autoimmune eg AIHA -Alloimmune e.g HDN, HTR -drug induced immune HA e.g methyl dopa – Red cell fragmentation syndromes – March haemoglobinuria – Infections – Chemical and physical agents. – PNH
  • 121.
    Immune HA Autoimmune HA( AIHA) ‱ These are caused by antibody production by the body itself against its own red cells. ‱ It is divided into warm and cold types according to whether the antibody reacts more strongly with red cells at 37O C or 4O C.
  • 122.
    AIHA classification Warm type ‱Idiopathic ‱ Secondary ‱ SLE, other autoimmune diseases ‱ CLL, lymphomas ‱ Drugs Cold type ‱ Idiopathic ‱ Secondary ‱ Infections- Mycoplasma pneumonia, Infectious mononucleosis. ‱ Lymphoma ‱ Paroxysmal cold haemoglobinuria.
  • 123.
    Laboratory findings inwarm AIHA ‱ Haematological and biochemical findings of extravascular haemolysis with spherocytosis prominent in the peripheral blood. ‱ Direct antiglobulin test is positive (Coombs test) as a result of IgG, IgG and complement or IgA on the cells.
  • 124.
    Warm AIHA ‱ anaemia,spherocytes and polychromatic macrocytes. The blood film in this condition occasionally shows small red cell agglutinates.
  • 125.
    Cold AIHA ‱ Theantibody attaches to red cells mainly in the peripheral circulation where the blood temperature is cooled. ‱ The AB is usually IgM and binds to red cells at 4o C. ‱ IgM antibodies are highly efficient in fixing complement. ‱ Both intravascular and extravascular haemolysis can occur.
  • 126.
    Laboratory findings incold AIHA ‱ Similar to those of warm AIHA, except that spherocytosis is less marked. ‱ Red cells agglutinate in the cold. ‱ DAT reveals complement (C3d) only on the red cell surface.( the AB having eluted off the cells in warmer parts of the circulation).
  • 127.
    Cold agglutinins ‱ verylarge red cell agglutinates form on spreading the blood film and and an abnormality can be appreciated on macroscopic inspection of the blood film. The nature of the abnormality can be confirmed by microscopic examination. If the blood is warmed before spreading, the degree of abnormality is much less.
  • 128.
    Cold AIHA ‱ Redcell clumping in cold AIHA
  • 129.
    Alloimmune HA ‱ Inthese anaemias, antibody produced by one individual reacts with red cells of another. ‱ Two important conditions – Transfusion of ABO incompatible blood – Rhesus disease of the newborn
  • 130.
    Rh-HDN ‱ Blood filmin rhesus haemolytic disease of the newborn showing several spherocytes.
  • 131.
    Non immune HA Redcell fragmentation syndromes ‱ They arise through physical damage to red cells on abnormal surfaces. – Artificial heart valves or arterial grafts. – Malignant hypertension – Haemolytic uraemic syndrome

.
  • 132.
    Mechanical HA (redcell fragmentation syndrome) ‱ There are macrocytes and red cell fragments.
  • 133.
    Non immune HA Infections ‱Malaria causes haemolysis by extravascular destruction of parasitised red cells as well as intravascular haemolysis accompanied by acute renal failure caused by Falciparum malaria. ‱ Clostridium perfringens  intravascular haemolysis.
  • 134.
    P.vivax ‱ Blood filmin P. vivax malaria.World-wide, malaria is a very common cause of haemolytic anaemia.
  • 135.
    Blood film inP. falciparum malaria a very heavy parasitaemia with numerous ring forms and one early gametocyte. World- wide,malaria is a very common cause of haemolytic anaemia. P. falciparum can cause acute intravascular haemolysis leading to 'blackwater fever'.
  • 136.
    Clostridium perfringens sepsis ‱. The blood film shows severe anaemia and marked spherocytosis. The spherocytosis is consequent on direct damage to the red cell membrane by a bacterial toxin.
  • 137.
    Non-immune HA Chemical andphysical agents - Certain drugs as dapsone and salazopyrine can cause oxidative intravascular haemolysis. - Severe burns damage red cells causing spherocytosis or acanthocytosis.
  • 138.
    Burns ‱ spherocytes and microspherocytes.. Theremay also be a 'packed film' consequent on elevation of the Hb as a result of loss of plasma into burnt tissues. A film as abnormal as this is usually associated with burns that are so severe that they are fatal.
  • 139.
    Non-immune HA Paroxysmal nocturnalhaemoglobinuria (PNH) ‱ This is a rare, acquired, clonal disorder ‱ The red cells are sensitive to lysis by complement and the result is chronic intravascular haemolysis.
  • 140.
    Pathophysiology of PNH ‱PNH is a rare, acquired disorder of marrow stem cells in which there is deficient synthesis of the glycosylphosphatidyl inositol (GPI) anchor,(a structure that attaches several surface proteins to the cell membrane).
  • 141.
    Cont
 ‱ It resultsfrom mutations in the X chromosome gene coding for phosphatidyl inositol glycan protein A (PIG-A) which is essential for the formation of the GPI anchor. ‱ GPI-linked proteins (such as CD55 and CD59) are absent from the abnormal stem cell surface of all the cells.
  • 142.
    Cont
 ‱ These proteins,CD59 or membrane inhibitor of reactive lysis (MIRL) and CD55 or decay accelerating factor (DAF), protects the red cell from being lysed by the membrane attack complex (C5–C8) that forms when complement (C) is activated and the result is chronic intravascular haemolysis.
  • 143.
    Cont
 ‱ Chronic intravascularhaemolysis in PNH is probably explained by activation of C through the „alternative‟ pathway ‱ CD55 and CD59 are also present on white cells and platelets. ‱ In addition to haemolytic anaemia, the patient may have thrombosis and pancytopenia.
  • 144.
    Clinical features 1. Haemoglobinuriadue to intravascular haemolysis 2. Haemolytic anaemia with a low platelet and/or low neutrophil count 3. Haemolytic anaemia and recurrent abdominal pain with or without blood in the stool. 4. Hepatic vein thrombosis (Budd–Chiari syndrome) 5. Any venous thrombosis anywhere in young adult with low platelet and/or the neutrophil counts. 6. Idiopathic pancytopenia (IAA).
  • 145.
  • 146.
    Diagnosis of PNH ‱Haemoglobinuria ‱ Haemosidrinuria ‱ Ham‟s test is positive in PNH. It shows red cell lysis in serum at low pH ‱ Flow cytometry to look for the loss of expression of GPI-linked proteins such as CD55 and CD59.
  • 147.